Updates are available Correction dated 2024-12-16
Click to view Correction: https://doi.org/10.1038/s41586-024-08519-1
-
Authors
Ramirez, Sydney I. https://orcid.org/0000-0002-7166-5195
Faraji, Farhoud https://orcid.org/0000-0001-5078-813X
Hills, L. Benjamin
Lopez, Paul G.
Goodwin, Benjamin
Stacey, Hannah D.
Sutton, Henry J. https://orcid.org/0000-0002-6472-7116
Hastie, Kathryn M.
Saphire, Erica Ollmann https://orcid.org/0000-0002-1206-7451
Kim, Hyun Jik https://orcid.org/0000-0001-8631-928X
Mashoof, Sara
Yan, Carol H.
DeConde, Adam S.
Levi, Gina
Crotty, Shane https://orcid.org/0000-0002-6484-6262
- License Information
-
More Information
Article History
Received: 6 December 2023
Accepted: 24 June 2024
First Online: 31 July 2024
Change Date: 16 December 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41586-024-08519-1
Competing interests
: S.C. has consulted for GSK, JP Morgan, Citi, Morgan Stanley, Avalia NZ, Nutcracker Therapeutics, University of California, California State Universities, United Airlines, Adagio, Sanofi and Roche. LJI has filed for patent protection for various aspects of T cell epitope and vaccine design work. The other authors declare no competing interests.
